title: Obstructive sleep apnea secondary to chronic lymphocytic leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Chehal
authors.forename: J H
authors.initials: JH
authors.lastname: Haidar
authors.forename: R
authors.initials: R
authors.lastname: Jabbour
authors.forename: B
authors.initials: B
authors.lastname: Yammout
authors.forename: A
authors.initials: A
authors.lastname: Bazarbachi
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001774:Blood Chemical Analysis; D001784:Blood Gas Analysis; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D017286:Polysomnography; D011241:Prednisone / Q000008:administration & dosage; D018570:Risk Assessment; D020181:Sleep Apnea, Obstructive / Q000175:diagnosis / Q000209:etiology*; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone